Mark Kloos

A Kinesin Heavy Chain (KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10)

Evan Reid, Mark Kloos, Allison E. Ashley‐Koch et al. · The American Journal of Human Genetics · 2002 · 533 citations · Full text

Biology, Mendelian Disorder, Genetic Disorder +8

Gene expression phenotypic models that predict the activity of oncogenic pathways

Erich Huang, Seiichi Ishida, Jennifer Pittman et al. · Nature Genetics · 2003 · 269 citations

Systems Biology, Signal Transduction, Oncogenic Pathways +10

Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations

Ingrid K. Svenson, Mark Kloos, P. C. Gaskell et al. · Neurogenetics · 2004 · 89 citations

Pain Syndrome, Pain Disorders, Kinesiology +8

A phase II prospective open‐label escalating dose trial of recombinant interleukin‐11 in mild von Willebrand disease

Margaret V. Ragni, Rachel C. Jankowitz, Holly Chapman et al. · Haemophilia · 2008 · 32 citations · Full text

Clinical Immunology, Immunology, Platelet Vwf +20

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies

Timothy C. Nichols, Dwight A. Bellinger, Elizabeth P. Merricks et al. · Thrombosis · 2010 · 29 citations · Full text

Vascular Disease, Immunology, Pathology +19